Biotechnology and biopharmaceutical firms were doing great until the day the COVID-19 pandemic changed the lives of the world's population, killing millions worldwide.

This distress impacted humanity's peace, stability and economy, bringing in unparalleled inflation, in addition to wars.   

Analysts told investors to buy a stocks and then told them to sell those same stocks a few days later.  This practice made our picked companies unfit for the Prohost Letter where we have our Portfolio. We temporarily stopped the Letter until the world's problems end. 

With regard to the Israel / Iran war, we expect that it . . .